Suppr超能文献

嫌色细胞肿瘤分级系统是嫌色性肾细胞癌的首选分级方案。

The chromophobe tumor grading system is the preferred grading scheme for chromophobe renal cell carcinoma.

机构信息

Institute of Urologic Oncology, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, California 90095, USA.

出版信息

J Urol. 2011 Dec;186(6):2168-74. doi: 10.1016/j.juro.2011.07.068. Epub 2011 Oct 19.

Abstract

PURPOSE

The prognostic usefulness of the Fuhrman nuclear grading system has been questioned for chromophobe renal cell carcinoma due to its frequent nuclear and nucleolar pleomorphism. Chromophobe tumor grade, a novel 3-tier tumor grading system based on geographic nuclear crowding and anaplasia, was recently reported to be superior to the Fuhrman system. We compared the 2 scoring systems in a large sporadic chromophobe renal cell carcinoma cohort to determine which grading scheme provides the most predictive assessment of clinical risk.

MATERIALS AND METHODS

We identified a total of 84 cases of sporadic chromophobe renal cell carcinoma in 82 patients from a total of 2,634 cases (3.2%) spanning 1989 to 2010. A subset of 11 tumors had secondary areas of sarcomatoid transformation. All cases were reviewed for Fuhrman nuclear grade and chromophobe tumor grade according to published parameters by an expert genitourinary pathologist blinded to clinicopathological information.

RESULTS

The distribution of Fuhrman nuclear grades 1 to 4 was 0%, 52.4%, 32.9% and 14.7% of cases, and the distribution of chromophobe tumor grades 1 to 3 was 48.8%, 36.5% and 14.7%, respectively. Metastasis developed in 20 patients (24.4%). Survival analysis revealed statistically significant differences in recurrence-free survival when adjusted for chromophobe tumor grade and Fuhrman nuclear grade. Chromophobe tumor grade showed a slightly higher AUC for recurrence-free survival and overall survival than the Fuhrman nuclear grading system. Neither chromophobe tumor grade nor Fuhrman nuclear grade was retained as an independent predictor of outcome in multivariate modeling when patients with sarcomatoid lesions were excluded.

CONCLUSIONS

Chromophobe tumor grade effectively stratifies patients with chromophobe renal cell carcinoma across all grading levels. Since it does not rely on nuclear features, it avoids the hazard of overestimating the malignant potential of chromophobe renal cell carcinoma. Overall chromophobe tumor grade has higher predictive accuracy than the Fuhrman nuclear grading system.

摘要

目的

由于嫌色细胞肾细胞癌的细胞核和核仁多形性频繁,富尔曼核分级系统的预后价值受到质疑。最近报道了一种新的基于核拥挤和间变的 3 级肿瘤分级系统——嫌色细胞瘤分级,优于富尔曼系统。我们在一个大型散发性嫌色细胞肾细胞癌队列中比较了这两种评分系统,以确定哪种分级方案对临床风险的预测评估最有帮助。

材料和方法

我们从 1989 年至 2010 年的 2634 例患者中总共发现了 82 例 84 例散发性嫌色细胞肾细胞癌患者。其中 11 例肿瘤有肉瘤样转化的次要区域。所有病例均由一名泌尿生殖系统病理学家根据发表的参数进行富尔曼核分级和嫌色细胞瘤分级评估,该病理学家对临床病理信息不知情。

结果

富尔曼核分级 1 级至 4 级的分布分别为 0%、52.4%、32.9%和 14.7%,嫌色细胞瘤分级 1 级至 3 级的分布分别为 48.8%、36.5%和 14.7%。20 例患者(24.4%)发生转移。生存分析显示,调整嫌色细胞瘤分级和富尔曼核分级后,无复发生存率有统计学差异。嫌色细胞瘤分级在无复发生存率和总生存率方面的 AUC 略高于富尔曼核分级系统。当排除肉瘤样病变患者时,无论是嫌色细胞瘤分级还是富尔曼核分级都不能作为独立的预后预测因子保留在多变量模型中。

结论

嫌色细胞瘤分级有效地对嫌色细胞肾细胞癌患者进行了分级。由于它不依赖于细胞核特征,因此避免了高估嫌色细胞肾细胞癌恶性潜能的风险。整体嫌色细胞瘤分级的预测准确性高于富尔曼核分级系统。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验